跳至主要内容
临床试验/CTRI/2019/06/019821
CTRI/2019/06/019821尚未招募4 期

To Study The Effect of Oral Mifepristone as an Adjunct to Other Methods of Pre-induction Cervical Ripening in Term Pregnancy â?? A Randomized Controlled trial

Paily V P0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • A. Primigravida singleton pregnancy at or more than 39 weeks gestation with cephalic presentation and intact membranes and no complications other than Gestational Diabetes Mellitus.
  • B. Modified Bishop Score less than 6.
  • C. Patient should not have any contraindications for vaginal delivery

排除标准

  • A. Multi-parity
  • B. Multiple pregnancy
  • C. Premature rupture of Membranes
  • D. Previous Cesarean Section
  • E. Scarred uterus
  • F. Uterine Anomalies
  • G. Malpresentations
  • H. Bad Obstetric History
  • I. Cephalo-pelvic Disproportion, Short Primi (height <145cm)
  • J. Indicated Induction for Gestational Hypertension, overt Diabetes and Gestational
  • Diabetes Mellitus on Insulin.
  • K. Fetal anamolies
  • L. Fetal growth restriction
  • M. Chronic Adrenal Failure
  • N Contraindications for oral Mifepristone
  • O. History of Allergic Reactions

研究者

发起方
Paily V P

相似试验